SCHEMBL4858649

SCHEMBL4858649

CSc1ccc(C(N)=Nc2ccc(C)c(C)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.50
NOS1 P29475 2/20 0.50
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
BLM P54132 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
CYP2D6 P10635 3/20 0.42
HIF1A Q16665 1/20 0.42
KMT2A Q03164 3/20 0.41
LMNA P02545 1/20 0.41
GFER P55789 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
MAPT P10636 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853071 0.82 CYP2D6 (0.64) NOS3NOS1CYP2D6HIF1AKMT2A
SCHEMBL4862318 0.80 KMT2A (0.60) NOS3NOS1POLBCYP2D6HIF1A
Hydrochloric Acid SCHEMBL11769944 0.79 KMT2A (0.58) NOS3NOS1POLBCYP2D6HIF1A
SCHEMBL4864124 0.78 NOS3 (0.58) NOS3NOS1POLBCYP2D6HIF1A
SCHEMBL4852965 0.78 NOS1 (0.58) NOS3NOS1POLBCYP2D6HIF1A
SCHEMBL4856119 0.78 NOS3 (0.58) NOS3NOS1POLBCYP2D6HIF1A
SCHEMBL4854767 0.78 NOS1 (0.58) NOS3NOS1CYP2D6HIF1AKMT2A
SCHEMBL4857038 0.78 NOS1 (0.58) NOS3NOS1CYP2D6HIF1AKMT2A
SCHEMBL4857014 0.77 MEN1 (0.66) NOS3NOS1POLBCYP2D6HIF1A
SCHEMBL4853087 0.76 GRIN2B (0.46) NOS3NOS1POLBCYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP NOS3 3830/4885NOS1 3074/4885POLB 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.